{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:24:02Z","timestamp":1792859042176,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.atherosclerosis.2006.09.029","type":"journal-article","created":{"date-parts":[[2006,11,14]],"date-time":"2006-11-14T07:18:59Z","timestamp":1163488739000},"page":"e80-e86","source":"Crossref","is-referenced-by-count":18,"title":["GLU-27 variant of \u03b22-adrenergic receptor polymorphisms is an independent risk factor for coronary atherosclerotic disease"],"prefix":"10.1016","volume":"194","author":[{"given":"Emanuele","family":"Barbato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Delrue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Van Durme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Manoharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Boussy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy R.","family":"Heyndrickx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"De Bruyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quirino","family":"Ciampi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Vanderheyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozef","family":"Bartunek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.atherosclerosis.2006.09.029_bib1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/01.CIR.0000153270.25541.72","article-title":"Role of beta 2 adrenergic receptors in human atherosclerotic coronary arteries","volume":"111","author":"Barbato","year":"2005","journal-title":"Circulation"},{"issue":"47","key":"10.1016\/j.atherosclerosis.2006.09.029_bib2","doi-asserted-by":"crossref","first-page":"14368","DOI":"10.1021\/bi00251a600","article-title":"Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties","volume":"33","author":"Green","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.atherosclerosis.2006.09.029_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1365-2796.2000.00721.x","article-title":"Polymorphisms of the \u03b22-adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in men","volume":"248","author":"Rosmond","year":"2000","journal-title":"J Intern Med"},{"key":"10.1016\/j.atherosclerosis.2006.09.029_bib4","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1172\/JCI119854","article-title":"Human beta-2 adrenoceptos gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function","volume":"100","author":"Large","year":"1997","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2006.09.029_bib5","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.amjhyper.2005.01.006","article-title":"Beta 2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals","volume":"18","author":"Masuo","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.atherosclerosis.2006.09.029_bib6","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/sj.ijo.0802129","article-title":"Gln27Glu polymorphism in the beta 2 adrenergic receptor gene and lipid metabolism during exercise in obese women","volume":"26","author":"Macho-Azcarate","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.atherosclerosis.2006.09.029_bib7","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1161\/01.CIR.101.25.2877","article-title":"Positional genomic analysis identifies the \u03b22-adrenergic receptor gene as a susceptibility locus for human hypertension","volume":"101","author":"Bray","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.09.029_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004872-200411000-00013","article-title":"The Glu27 allele of the \u03b22 adrenergic receptor increases the risk of cardiac hypertrophy in hypertension","volume":"22","author":"Iaccarino","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.atherosclerosis.2006.09.029_bib9","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa021445","article-title":"Prediction of the risk of myocardial infarction from polymorphisms in candidate genes","volume":"347","author":"Yamada","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2006.09.029_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00004872-200202000-00012","article-title":"Polymorphisms of the \u03b22-adrenoceptor (ADRB2) gene and essential hypertension: the ECTIM and PEGASE studies","volume":"20","author":"Herrmann","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.atherosclerosis.2006.09.029_bib11","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1161\/01.CIR.0000065231.07729.92","article-title":"\u03b22-Adrenergic receptor polymorphisms and risk of incident cardiovascular events in the elderly","volume":"107","author":"Heckbert","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.09.029_bib12","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1534\/genetics.104.037812","article-title":"Haplotype analysis of the \u03b22 adrenergic receptor gene and risk of myocardial infarction in humans","volume":"169","author":"Zee","year":"2005","journal-title":"Genetics"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2006.09.029_bib13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1538-7836.2006.01754.x","article-title":"Multi-locus candidate gene polymorphisms and risk of myocardial infarction: a population-based, prospective genetic analysis","volume":"4","author":"Zee","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2006.09.029_bib14","first-page":"151","article-title":"World Health Organization-International Society of Hypertension Guidelines for the Management of, Hypertension","volume":"17","author":"Guidelines, Subcommittee","year":"1999","journal-title":"J Hypertens"},{"key":"10.1016\/j.atherosclerosis.2006.09.029_bib15","unstructured":"World Health Organization Study Group. Diabetes mellitus. WHO Tech Rep Ser 1985; 727:1-104."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2006.09.029_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/01.RES.51.1.56","article-title":"Regulation of large coronary arteries by beta-adrenergic mechanisms in the conscious dog","volume":"51","author":"Vatner","year":"1982","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2006.09.029_bib17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/01.CIR.79.4.797","article-title":"Effects of regional alpha- and beta-blockade on resting and hyperemic coronary blood flow in conscious, unstressed humans","volume":"79","author":"Hodgson","year":"1989","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2006.09.029_bib18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00005344-199501000-00021","article-title":"Beta-adrenoceptor subtypes in human coronary artery: desensitization of beta2-adrenergic vasorelaxation by chronic beta1-adrenergic stimulation in vitro","volume":"25","author":"Ferro","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2006.09.029_bib19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/01.HYP.36.3.371","article-title":"Beta2-adrenoceptor polymorphism determines vascular reactivity in humans","volume":"36","author":"Cockcroft","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2006.09.029_bib20","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1056\/NEJMoa010819","article-title":"The effect of common polymorphisms of the beta 2-adrenergic receptor on agonist-mediated vascular desensitization","volume":"345","author":"Dishy","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2006.09.029_bib21","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1126\/science.6836311","article-title":"Social stress and atherosclerosis in normocholesterolemic monkeys","volume":"220","author":"Kaplan","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2006.09.029_bib22","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/01.CIR.76.6.1364","article-title":"Inhibition of coronary atherosclerosis by propranolol in behaviourally predisposed monkeys fed an atherogenic diet","volume":"76","author":"Kaplan","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.09.029_bib23","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1161\/01.CIR.103.13.1721","article-title":"Low-dose metoprolol CR\/XL and fluvastatin slow progression of carotid intima-media thickness: main results from the \u03b2-blocker cholesterol-lowering asymptomatic plaque study (BCAPS)","volume":"103","author":"Hedblad","year":"2001","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2006.09.029_bib24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.tpj.6500324","article-title":"Beta-Blockade and increased dyslipidemia in patients bearing Glu27 variant of beta2 adrenergic receptor gene","volume":"5","author":"Iaccarino","year":"2005","journal-title":"Pharmacogenomics"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915006005922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915006005922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T09:29:14Z","timestamp":1547198954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915006005922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0021915006005922"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.09.029","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}